JPRN-jRCT1031230091
Recruiting
未知
AN OBSERVATIONAL STUDY EVALUATING TREATMENT SITUATION OF ADJUVANT NIVOLUMAB FOR MUSCLE-INVASIVE UROTHELIAL CARCINOMA IN JAPAN - ANNIVERSARY
AKANO TOMOYOSHI0 sites400 target enrollmentMay 26, 2023
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Muscle invasive urothelial carcinoma
- Sponsor
- AKANO TOMOYOSHI
- Enrollment
- 400
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Patients aged 18 years or older
- •2\) Patients with histologically definitive diagnosis of MIUC at each study site and who received nivolumab after radical resection
- •3\) Patients who present at least once to the study site after nivolumab treatment or who have survival data
- •4\) In the case of a patient who is currently visiting a study site participating in the study, the patient must be fully informed of their enrollment in the study and provide written consent of his/her own free will after sufficient understanding.
Exclusion Criteria
- •Patients who did not meet any of the following criteria at the time of obtaining consent will not be included in this study.
- •1\) Patients who underwent only partial resection for MIUC
- •2\) Patients treated with chemotherapy, radiotherapy, biologics (anticancer agents), intravesical chemotherapy, or BCG therapy from the time of radical resection of MIUC to the start of nivolumab
- •3\) Those who received investigational drugs after being diagnosed with MIUC and before or administered nivolumab
- •4\) Patients previously treated with immune checkpoint inhibitors prior to nivolumab treatment
- •5\) Patients judged to be inappropriate for enrollment in this study by the investigator at each participating study site
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
An observational study investigating the treatment satisfaction of atopic dermatitis patients who have switched to ointment (W/O emulsion) formulation of Very Strong Class topical corticosteroidsatopic dermatitisJPRN-UMIN000019873Mie University Hospital60
Completed
Not Applicable
Prospective observational study of the treatment and prognosis in patients with relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation.Adult T-cell leukemia-lymphomaJPRN-UMIN000009251JSCT30
Recruiting
Not Applicable
Prospective observational study of the treatment and prognosis in patients with previously untreated indolent B cell lymphomaIndolent B-cell Non-Hodgkin's lymphomaJPRN-UMIN000010175Fukuoka Lymphoma Study Group200
Recruiting
Not Applicable
An observational clinical study to assess and assessment of the risk of bleeding after dentoalveolar procedures with Medication with direct oral anticoagulants (DOAKs), antiplatelet agents, and vitamin K antagonists.D68.33Z92.1D68.35Personal history of long-term (current) use of anticoagulantsDRKS00024889Mund-Kiefer- und Gesichtschirurgische KlinikFAU Uniklinik Erlangen300
Recruiting
Not Applicable
Prospective Study Evaluating The Treatment Outcomes For Localised Recurrent, Resectable Retroperitoneal LiposarcomaRetroperitoneal Liposarcoma (LPS)Cancer - Sarcoma (also see 'Bone') - soft tissueACTRN12624000554561Australia and New Zealand Sarcoma Association100